News
CELUW
0.0019
0.00%
0.0000
Weekly Report: what happened at CELU last week (0914-0918)?
Weekly Report · 12h ago
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga · 3d ago
Celularity Restores Nasdaq Compliance on Key Listing Standards
TipRanks · 09/14 13:29
Celularity Says It Regained Compliance With Nasdaq Minimum Bid Price And Market Value Of Listed Securities Rules; Delinquent Periodic Filing Deficiency Remains Outstanding
Benzinga · 09/14 13:05
Weekly Report: what happened at CELU last week (0907-0911)?
Weekly Report · 09/14 10:01
Weekly Report: what happened at CELU last week (0831-0904)?
Weekly Report · 09/07 09:56
Weekly Report: what happened at CELU last week (0824-0828)?
Weekly Report · 08/31 10:01
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/28 17:05
Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal
NASDAQ · 08/28 14:42
Why Is Celularity Stock Gaining Thursday?
Benzinga · 08/27 17:42
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 08/27 17:06
Why Is Penny Stock Celularity (CELU) Up 115% Today?
TipRanks · 08/27 16:34
Reported Earlier: Celularity And MuseCell Innovations Expand U.S. Manufacturing Collaboration, With Potential For $300M+ In Purchases Over Five Years
Benzinga · 08/27 14:34
Celularity Expands Cellular Medicine Manufacturing With MuseCell Innovations Partnership; Stock
NASDAQ · 08/27 14:33
Celularity, MuseCell Innovations announce U.S. manufacturing collaboration
TipRanks · 08/27 13:05
Celularity To Begin U.S. Production Of MuseCell Innovations' Dezawa MuseCells At Its New Jersey Facility
Benzinga · 08/27 13:03
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 08/26 12:06
Celularity receives Nasdaq non-compliance notice over delayed 10-Q filings
Seeking Alpha · 08/26 07:07
Celularity Faces Nasdaq Compliance Issue Over Delayed 10-Q Filings
NASDAQ · 08/26 00:59
Celularity Provides Update Regarding Nasdaq Listing Compliance
Barchart · 08/25 18:59
More
Webull provides a variety of real-time CELUW stock news. You can receive the latest news about Celularity Inc through multiple platforms. This information may help you make smarter investment decisions.
About CELUW
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells (MLASCs), T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It also develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance and Interfyl products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).